[(177)Lu]Lu-PSMA-617 in Patients with Progressive PSMA+ mCRPC Treated With or Without Prior Taxane-Based Chemotherapy: A Phase 2, Open-Label, Single-Arm Trial in Japan
[(177)Lu]Lu-PSMA-617 治疗既往接受过或未接受过紫杉烷类化疗的进展性 PSMA+ mCRPC 患者:一项在日本开展的 II 期、开放标签、单臂试验
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17142351
Izumi, Kouji; Matsumoto, Ryuji; Ito, Yusuke; Hoshi, Seiji; Matsubara, Nobuaki; Yamasaki, Toshinari; Mizowaki, Takashi; Komaru, Atsushi; Nomura, Satoshi; Hattori, Toru; Kambara, Hiroya; Alanee, Shaheen; Hosono, Makoto; Kinuya, Seigo